DRAVET SYNDROME
Clinical trials for DRAVET SYNDROME explained in plain language.
Never miss a new study
Get alerted when new DRAVET SYNDROME trials appear
Sign up with your email to follow new studies for DRAVET SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare seizure sufferers: Long-Term drug safety confirmed
Disease control CompletedThis study looked at the long-term safety of a drug called fenfluramine (ZX008) for people with rare seizure disorders like Dravet syndrome and Lennox-Gastaut syndrome. Over 400 participants who had already completed a previous study took the drug for an extended period. The main…
Matched conditions: DRAVET SYNDROME
Phase: PHASE3 • Sponsor: Zogenix, Inc. • Aim: Disease control
Last updated May 17, 2026 05:02 UTC
-
New epilepsy drug shows promise in long-term safety trial for rare brain conditions
Disease control CompletedThis study looked at the long-term safety of a drug called LP352 in people aged 12 to 65 with severe epilepsy and developmental problems, including Dravet and Lennox-Gastaut syndromes. All 41 participants had already completed an earlier study and continued treatment for up to 52…
Matched conditions: DRAVET SYNDROME
Phase: PHASE2 • Sponsor: Longboard Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 12:07 UTC
-
Healthy volunteers test new liquid version of seizure drug
Knowledge-focused CompletedThis study tested two forms of the seizure medication stiripentol (capsule and liquid) in 24 healthy adults to see if the liquid version works the same way in the body. Participants took a single dose of each form, and researchers measured drug levels in the blood. The goal is to…
Matched conditions: DRAVET SYNDROME
Phase: PHASE1 • Sponsor: Biocodex • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC